Treatment-Free Remission Following Frontline Nilotinib in Patients With Chronic-Phase CML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Treatment-Free Remission Following Frontline Nilotinib in Patients With Chronic Phase Chronic Myeloid Leukemia: 5-Year Update of the ENESTfreedom Trial
Leukemia 2021 Mar 11;[EPub Ahead of Print], JP Radich, A Hochhaus, T Masszi, A Hellmann, J Stentoft, MTG Casares, JV García-Gutiérrez, E Conneally, PD le Coutre, N Gattermann, B Martino, S Saussele, FJ Giles, DM Ross, P Aimone, S Li, K Titorenko, G SaglioFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.